Bleil Lynn Dorsey - Insider Non-Derivative Transactions at AMICUS THERAPEUTICS, INC. (FOLD) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 6, 2024, Bleil Lynn Dorsey's relationship to AMICUS THERAPEUTICS, INC. (FOLD) is Director, and currently has 93,527 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FOLD insiders.
Data Source: SEC.
Bleil Lynn Dorsey - Insider Non-Derivative Transactions of FOLD Common Stock
Bleil Lynn Dorsey - Insider Non-Derivative Transactions at FOLD
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 7, 2024 | Acquisition -- (Common Stock) | 11847 | 0 | 93527 |
| Jun 9, 2023 | Acquisition -- (Common Stock) | 8584 | 0 | 81680 |